Seqirus to discontinue Benpen injection products

Manufacturer confirms plans to phase out its Benpen injection products from November 2026  Commercial reasons are behind Seqirus’s decision to discontinue its Benpen (benzylpenicillin sodium) injectable antibiotic products, the Therapeutic Goods Administration (TGA) reports.   The regulator confirmed the company had notified it of its plans to progressively discontinue the range from 30 November 2026.   “The discontinuations are due to commercial decisions and are not related to product